Mannkind

By bigkahuana, April 25, 2014

Doc Gumshoe, any thoughts on the inhaled insulin that Mannkind MNKD has and is about to be voted on for FDA approval in July. Seems to me that this is a blockbuster grug for a small company that could make the stock take off. Your opinion would be highly appreciated as I’m ready to buy this stock now but am trying to get a better grip on the potential of this drug.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

5
Share your thoughts...

avatar
5 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
4 Comment authors
Eliott SedleckskySparky SantosR.Nemanomcdac1 Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

omcdac1
Member
πŸ‘468
omcdac1

Mannkind is not making or bringing anything blockbuster. Yes stock can take off for some time.
But it is not something like BNIKF that is real blockbuster. Dr Kss is talking about BNIKF for 3 months now. That is going to be real winner.

Add a Topic
5971
Add a Topic
3932
omcdac1
Member
πŸ‘468
omcdac1

I had asked the same question from Dr kss about mankind. He doesn’t own MNKD.

Add a Topic
3932
R.Neman
Guest
R.Neman

MNKD can go either way. depends on FDA approval. Can go low as $6.00or as high as $16.00

Add a Topic
3022
stsparky
Member
πŸ‘3
stsparky

They’ve a foreign partner now. I’m hoping higher than $20.

Elliot
Member
πŸ‘502

I think most of Mannkind’s value lies in the Technosphere platform. I’m not convinced Afrezza will ever gain significant adoption, but I hold a small number of shares because I believe Technosphere could be huge some day, particularly for things like inhaled pain treatment and inhaled erectile dysfunction treatment, if ever pursued.